HURA

TuHURA Biosciences, Inc. - Common Stock (HURA)

About TuHURA Biosciences, Inc. - Common Stock (HURA)

TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. The company was founded on May 4, 2023 and is headquartered in Tampa, FL.

Details

Daily high

$4.19

Daily low

$3.90

Price at open

$4.10

52 Week High

$7.93

52 Week Low

$1.80

Market cap

179.1M

Dividend yield

0.00%

Volume

149,056

Avg. volume

189,594

P/E ratio

-.05

TuHURA Biosciences, Inc. - Common Stock News